Parabilis Medicines, Inc.PBLS

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$32.47
Market cap
$4.0B
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—

What Parabilis Medicines, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year20242025

More on PBLS.

Figures from Parabilis Medicines, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.